54 related articles for article (PubMed ID: 1338386)
1. The human pharmacology of fluoxetine.
Lucas RA
Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S49-54. PubMed ID: 1338386
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine: clinical pharmacology and physiologic disposition.
Lemberger L; Bergstrom RF; Wolen RL; Farid NA; Enas GG; Aronoff GR
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):14-9. PubMed ID: 3871765
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhibitors of neuronal uptake of 5-HT on sympathetic cardiovascular regulation.
Szabo B; Karsch V; Starke K
J Cardiovasc Pharmacol; 1992 Jul; 20(1):99-107. PubMed ID: 1383637
[TBL] [Abstract][Full Text] [Related]
4. Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses.
Saletu B; Grünberger J
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):45-52. PubMed ID: 3882681
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the selective serotonin reuptake inhibitors.
DeVane CL
J Clin Psychiatry; 1992 Feb; 53 Suppl():13-20. PubMed ID: 1531816
[TBL] [Abstract][Full Text] [Related]
6. Toxicokinetics, disposition and metabolism of fluoxetine in crabs.
Robert A; Schultz IR; Hucher N; Monsinjon T; Knigge T
Chemosphere; 2017 Nov; 186():958-967. PubMed ID: 28830067
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine impairs clearance of alprazolam but not of clonazepam.
Greenblatt DJ; Preskorn SH; Cotreau MM; Horst WD; Harmatz JS
Clin Pharmacol Ther; 1992 Nov; 52(5):479-86. PubMed ID: 1424422
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine disposition and elimination in cirrhosis.
Schenker S; Bergstrom RF; Wolen RL; Lemberger L
Clin Pharmacol Ther; 1988 Sep; 44(3):353-9. PubMed ID: 3262026
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine kinetics and protein binding in normal and impaired renal function.
Aronoff GR; Bergstrom RF; Pottratz ST; Sloan RS; Wolen RL; Lemberger L
Clin Pharmacol Ther; 1984 Jul; 36(1):138-44. PubMed ID: 6610522
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine.
Hall J; Naranjo CA; Sproule BA; Herrmann N
J Clin Psychopharmacol; 2003 Aug; 23(4):349-57. PubMed ID: 12920410
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition.
Deodhar M; Rihani SBA; Darakjian L; Turgeon J; Michaud V
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498694
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine, a selective inhibitor of serotonin uptake.
Fuller RW; Wong DT; Robertson DW
Med Res Rev; 1991 Jan; 11(1):17-34. PubMed ID: 1994152
[TBL] [Abstract][Full Text] [Related]
13. Effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanol.
Lemberger L; Rowe H; Bergstrom RF; Farid KZ; Enas GG
Clin Pharmacol Ther; 1985 Jun; 37(6):658-64. PubMed ID: 3874037
[TBL] [Abstract][Full Text] [Related]
14. In vitro effect of phencyclidine and other psychomotor stimulants on serotonin uptake in human platelets.
Arora RC; Meltzer HY
Life Sci; 1980 Oct; 27(17):1607-13. PubMed ID: 6969339
[No Abstract] [Full Text] [Related]
15. Fluoxetine, pharmacology and physiologic disposition.
Lemberger L; Farid NA; Bergstrom RF; Wolen RL
Int J Obes; 1987; 11 Suppl 3():157-61. PubMed ID: 3501991
[No Abstract] [Full Text] [Related]
16. An
Chow TW; Nguyen TA; Riggs KW; Rurak DW
Xenobiotica; 2019 Nov; 49(11):1360-1372. PubMed ID: 30587071
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of fluoxetine.
Altamura AC; Moro AR; Percudani M
Clin Pharmacokinet; 1994 Mar; 26(3):201-14. PubMed ID: 8194283
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling.
Guest PC; Knowles MR; Molon-Noblot S; Salim K; Smith D; Murray F; Laroque P; Hunt SP; De Felipe C; Rupniak NM; McAllister G
Brain Res; 2004 Mar; 1002(1-2):1-10. PubMed ID: 14988027
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Benfield P; Heel RC; Lewis SP
Drugs; 1986 Dec; 32(6):481-508. PubMed ID: 2878798
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
